LAUSR

Aims: The aim of the study is to evaluate the neuroprotective effects of olfactory ensheathing cells (OECs) with the overexpression of nuclear receptor‐related factor 1 (Nurr1) and neurogenin 2 (Ngn2) in experimental models of Parkinson's disease (PD) and to elucidate the potential mechanism underlying the neuroprotective effects of OECs‐Nurr1‐Ngn2. Materials and methods: In vitro study, OECs‐Nurr1‐Ngn2 conditioned medium (CM) was added to MPP+‐treated PC12 cells for 24 h, and then the viability of PC12 cells, oxidative stress and apoptosis were detected. In vivo study, 48 male Sprague‐Dawley (SD) rats were randomly divided into four groups. OECs/VMCs and OECs‐Nurr1‐Ngn2/VMCs groups were transplanted with 2 × 105 cells each of OECs or OECs‐Nurr1‐Ngn2 and VMCs into the right striatum one week after a unilateral 6‐OHDA lesion. Control and PD groups were injected with 0.9% NaCl and 0.2% ascorbic acid into the same region. Rotational behavior was determined at 2, 4, 6 and 8 weeks after injection or implantation in all groups. Neuronal differentiation markers, oxidative stress‐ and apoptosis‐related indicators were detected at 8 weeks post‐grafting. Key findings: OECs‐Nurr1‐Ngn2 increased the viability of PC12 cells, inhibited oxidative stress and apoptosis, and these effects could be reversed by pre‐treatment of k252a, a TrkB receptor inhibitor. The behavioral deficits of PD rat were ameliorated by the transplantation of OECs‐Nurr1‐Ngn2/VMCs. Significance: These results suggest that OECs‐Nurr1‐Ngn2 exhibits substantial neuroprotective, anti‐oxidant, and anti‐apoptotic effects against PD via the up‐regulation of the neurotrophic factor‐TrkB pathway.